Literature DB >> 24450685

Wrist and ankle MRI of patients with juvenile idiopathic arthritis: identification of unsuspected multicompartmental tenosynovitis and arthritis.

Sanaz Javadi1, J Herman Kan, Robert C Orth, Marietta DeGuzman.   

Abstract

OBJECTIVE: The purpose of this study was to characterize the extent of joint and tendon involvement in patients with juvenile idiopathic arthritis referred for MRI of the wrist or ankle.
MATERIALS AND METHODS: Forty-five patients (32 female and 13 male patients; mean age, 10 years; age range, 1-19 years) with an established diagnosis of juvenile idiopathic arthritis were referred for MRI of the wrist or ankle between January 2000 and August 2012 (39 wrists and 33 ankles). All MRI examinations and clinical notes were reviewed, and joint and tendon involvement was recorded.
RESULTS: Tenosynovitis was present in 50% (36/72) of examinations. Tenosynovitis was not documented in clinical notes before MRI. When tenosynovitis was present, an average of 3.5 tendons were involved (range, 1-12 tendons). For the wrist, 59% (23/39) had tenosynovitis, and the extensor digitorum tendon (23% [9/39]) was most commonly involved. For the ankle, 39% (13/33) had tenosynovitis, and the tibialis posterior tendon (33.3% [11/33]) was most commonly involved. For the wrist, 89.7% (35/39) had active joint inflammation with an average of 3.1 joints involved (range, 0-6 joints), and the intercarpal joint was most commonly involved (69% [27/39]). For the ankle, 69.7% (23/33) had active joint inflammation, with an average of 2.4 joints involved (range, 0-5 joints), and the tibiotalar joint (52% [17/33]) was most commonly involved.
CONCLUSION: Multicompartmental tenosynovitis and arthritis involvement is common in patients with juvenile idiopathic arthritis referred for MRI of the wrist or ankle and is underappreciated on clinical examination. International League of Associations for Rheumatology subclassification and targeted intraarticular steroid injections guided by clinical examination alone may lead to undertreatment or incorrect treatment of active disease.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24450685     DOI: 10.2214/AJR.13.10671

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

Review 1.  Management of juvenile idiopathic arthritis: hitting the target.

Authors:  Claas Hinze; Faekah Gohar; Dirk Foell
Journal:  Nat Rev Rheumatol       Date:  2015-01-06       Impact factor: 20.543

2.  Physical Examination Tool for Swollen and Tender Lower Limb Joints in Juvenile Idiopathic Arthritis: A Pilot Diagnostic Accuracy Study.

Authors:  Antoni Fellas; Davinder Singh-Grewal; Jeffrey Chaitow; Denise Warner; Ella Onikul; Derek Santos; Matthew Clapham; Andrea Coda
Journal:  Int J Environ Res Public Health       Date:  2022-04-08       Impact factor: 4.614

3.  An undiagnosed pleural effusion with surprising consequences.

Authors:  A G Casalini; F Cusmano; N Sverzellati; P A Mori; M Majori
Journal:  Respir Med Case Rep       Date:  2017-05-26

4.  Ultrasound-guided steroid tendon sheath injections in juvenile idiopathic arthritis: a 10-year single-center retrospective study.

Authors:  Shannon E Peters; Ronald M Laxer; Bairbre L Connolly; Dimitri A Parra
Journal:  Pediatr Rheumatol Online J       Date:  2017-04-11       Impact factor: 3.054

5.  Ankle Magnetic Resonance Imaging in Juvenile Idiopathic Arthritis Versus Non-Juvenile Idiopathic Arthritis Patients with Arthralgia.

Authors:  Monika Ostrowska; Emil Michalski; Piotr Gietka; Małgorzata Mańczak; Magdalena Posadzy; Iwona Sudoł-Szopińska
Journal:  J Clin Med       Date:  2022-01-30       Impact factor: 4.241

6.  Reliability of ultrasonography to detect inflammatory lesions and structural damage in juvenile idiopathic arthritis.

Authors:  Lucio Ventura-Ríos; Enrique Faugier; Laura Barzola; L B De la Cruz-Becerra; Guadalupe Sánchez-Bringas; Andrés Rodríguez García; Rocío Maldonado; Johannes Roth; Cristina Hernández-Díaz
Journal:  Pediatr Rheumatol Online J       Date:  2018-09-17       Impact factor: 3.054

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.